Celldex Therapeutics, Price Chart
Celldex Therapeutics, Volume Chart
Celldex Therapeutics, Market Segments
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
-0.19(-0.46%)
| Open | $41.56 |
|---|---|
| Close | $41.37 |
| Low | $41.37 |
| Low Change | -0.19 (-0.46%) |
| High | $41.70 |
| High Change | +0.14 (+0.34%) |
| Range | $0.33 |
| Volume | 137.599K |
| Dollar Volume | $5.69M |
Regular Trading Hours Yesterday
+0.57(+1.39%)
| Open | $41.03 |
|---|---|
| Close | $41.60 |
| Low | $40.84 |
| Low Change | -0.19 (-0.46%) |
| High | $41.74 |
| High Change | +0.71 (+1.73%) |
| Range | $0.90 |
| Volume | 652.786K |
| Dollar Volume | $27.16M |
Premarket Yesterday
-0.33(-0.79%)
| Open | $41.54 |
|---|---|
| Close | $41.21 |
| Low | $41.10 |
| Low Change | -0.44 (-1.06%) |
| High | $41.54 |
| High Change | +0.00 (+0.00%) |
| Range | $0.44 |
| Volume | 2.792K |
| Dollar Volume | $115.06K |
Celldex Therapeutics, News
Celldex Therapeutics, Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Celldex Therapeutics, Moving Averages
| 5 Day Moving Average (SMA5) | $39.49 |
|---|---|
| 10 Day Moving Average (SMA10) | $38.00 |
| 20 Day Moving Average (SMA20) | $37.31 |
| 50 Day Moving Average (SMA50) | $34.84 |
| 100 Day Moving Average (SMA100) | $33.47 |
| 200 Day Moving Average (SMA200) | $29.91 |
Celldex Therapeutics, Statistics
| Average Volume (30 Days) | 1.18M |
|---|---|
| P/E Ratio (Current) | -11.37 |
| EPS (Current) | -$3.61 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$226.25M |
| Cash Ratio | 0.69 |
| Current Ratio | 8.92 |
| Quick Ratio | 8.92 |
| Debt to Equity | 0.00 |
| Enterprise Value | $3.19B |
| EV to EBITDA | -10.43 |
| EV to Sales | 3680.32 |
| Price to Book | 7.06 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 3721.58 |
| Return on Assets | -0.55% |
| Return on Equity | -0.62% |
Celldex Therapeutics, Stock Splits
There have been 2 stock splits for Celldex Therapeutics, (CLDX). The last reverse stock split occured on February 11, 2019 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| Feb 11, 2019 | Reverse | 15:1 |
| Mar 7, 2008 | Reverse | 12:1 |
Celldex Therapeutics, Dividends
There have been no dividends for Celldex Therapeutics, (CLDX).